Skip to main content
SpringerLink
Log in

The Role of ACE-Inhibitors in Patients with Coronary Artery Disease

  • Editorial Introduction
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145-53.

    Google Scholar 

  2. Keidar S,Kaplan M,Aviram M. Angiotensin II-modified LDL is taken up by macrophages via the scavenger receptor, leading to cellular cholesterol accumulation. Aterioscler Thromb Vasc Biol 1996; 16: 97-05.

    Google Scholar 

  3. Mancini GBJ,Henry GC,Macaya C, et al. Angiotensinconverting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 1996; 94: 258-65.

    PubMed  Google Scholar 

  4. Pepine CJ,Pitt B,Bertrand ME,Timmis A. Emerging role of ACE inhibitors in vascular protection. J Myocard Ischemia 1995; 7(suppl 1): 50-58.

    Google Scholar 

  5. Lonn EM,Yusuf S,Jha P, et al. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation 1994; 90: 2056-69.

    PubMed  Google Scholar 

  6. Furberg CD,Pitt B. Are all angiotensin-converting enzyme inhibitors interchangeable. J Am Coll Cardiol 2001; 37: 1456-60.

    PubMed  Google Scholar 

  7. Lonn EM,Yusuf S,Dzavik V, et al. Effects of ramipril and vitamin E on atherosclerosis: The study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001; 103: 919-25.

    PubMed  Google Scholar 

  8. Texter M,Lees RS,Pitt B, et al. The quniapril ischemic event trial (QUIET) design and methods: Evaluation of chronic ACE inhibitor therapy after coronary artery intervention. Cardiovascular Drugs Ther 1993; 7: 273-82. The Role of ACE-Inhibitors 105

    Google Scholar 

  9. Teo K,Burton J,Buller C, et al. Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis. Circulation 2000; 102: 1748-54.

    PubMed  Google Scholar 

  10. MacMahon S,Sharpe N,Gamble G, et al. Randomized, placebo-controlled trial of th eangiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. J Am Coll Cardiol 2000; 36: 438-43.

    PubMed  Google Scholar 

  11. Ohishi M,Ueda M,Rakugi H,Naruko T,Kojima A,Okamura A, et al. Relative localization of angiotensinconverting enzyme, chymase and angiotensin II in human coronary atherosclerotic lesions. J Hypertens 1999; 17: 547-53.

    PubMed  Google Scholar 

  12. Potter DD,Sobey CG,Tompkins PK,Rossen JD,Heistad DD. Evidence that macrophages in atherosclerotic lesions contain angiotensin II. Circulation 1998; 98: 800-07.

    PubMed  Google Scholar 

  13. Warnholtz A,Nickenig G,Schulz E,Macharzina R,Brasen JH,Skatchkov M, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: Evidence for involvement of the renin-angiotensin system. Circulation 1999; 15: 2027-33.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Michigan, Ann Arbor, Michigan

    Bertram Pitt

Authors
  1. Bertram Pitt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pitt, B. The Role of ACE-Inhibitors in Patients with Coronary Artery Disease. Cardiovasc Drugs Ther 15, 103–105 (2001). https://doi.org/10.1023/A:1011110526379

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011110526379

Search

Navigation